ZOGENIX INC's ticker is ZGNX and the CUSIP is 98978L204. A total of 161 filers reported holding ZOGENIX INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $482,000 | -34.2% | 29,635 | -30.1% | 0.01% | -37.5% |
| Q2 2021 | $733,000 | -44.0% | 42,403 | -36.7% | 0.01% | -52.9% |
| Q1 2021 | $1,308,000 | -27.5% | 67,015 | -25.8% | 0.02% | -32.0% |
| Q4 2020 | $1,805,000 | -2.5% | 90,308 | -12.6% | 0.02% | -7.4% |
| Q3 2020 | $1,852,000 | +20.2% | 103,308 | +81.1% | 0.03% | 0.0% |
| Q2 2020 | $1,541,000 | +32.2% | 57,053 | +155.2% | 0.03% | +28.6% |
| Q4 2019 | $1,166,000 | +302.1% | 22,359 | +209.2% | 0.02% | +250.0% |
| Q3 2019 | $290,000 | -15.7% | 7,231 | +0.3% | 0.01% | 0.0% |
| Q2 2019 | $344,000 | -28.0% | 7,210 | -25.3% | 0.01% | -76.9% |
| Q3 2018 | $478,000 | +635.4% | 9,647 | +497.0% | 0.03% | +550.0% |
| Q1 2018 | $65,000 | -71.2% | 1,616 | -74.9% | 0.00% | -69.2% |
| Q3 2017 | $226,000 | -14.4% | 6,438 | -67.1% | 0.01% | 0.0% |
| Q3 2015 | $264,000 | – | 19,567 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 971,875 | $24,034,000 | 14.58% |
| Eversept Partners, LP | 2,013,467 | $49,793,039 | 12.38% |
| Pinz Capital Management, LP | 98,800 | $2,443,000 | 6.40% |
| RA Capital Management | 5,275,538 | $130,464,000 | 4.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,797 | $6,955,000 | 3.17% |
| Granite Point Capital Management, L.P. | 203,462 | $5,032,000 | 2.84% |
| Avoro Capital Advisors LLC | 2,800,000 | $69,244,000 | 2.34% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,029,699 | $25,464,000 | 2.33% |
| Eventide Asset Management | 2,841,300 | $70,265,000 | 2.28% |
| Perceptive Advisors | 3,452,921 | $85,390,000 | 2.22% |